Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07298915) titled 'The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED)' on Dec. 19, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: University of Virginia
Condition:
Obesity & Overweight
Intervention:
Drug: Tirzepatide
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: February 2026
Target Sample Size: 24
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07298915
Published by HT Digital ...